NCT00235833 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00235820 Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT00234936 Quality of Life Study With Adalimumab in Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00234897 Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT00234884 Post-marketing Observational Study in Subjects With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT00234845 Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00234234 Predictors of the Response to Adalimumab in Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT00216177 Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis Status UNKNOWN Phase PHASE4
NCT00195715 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease Status COMPLETED Phase PHASE3
NCT00195702 Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate. Status COMPLETED Phase PHASE3
NCT00195676 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT00195663 Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT00185562 A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis Status COMPLETED Phase PHASE2
NCT00105300 Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease Status COMPLETED Phase PHASE3
NCT00077779 Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease Status COMPLETED Phase PHASE3
NCT00049751 Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3